Back to Trades
Other4
HALOZYME THERAPEUTICS, INC.
HALO
Total Value
$1.5M
Company Information
- Company Name
- HALOZYME THERAPEUTICS, INC.
- Ticker Symbol
- HALO
- CIK
- 0001159036
Insider Information
- Name
- Torley Helen
- Role
- PRESIDENT AND CEO, Director
- Location
- SAN DIEGO, CA
DirectorOfficer
Filing Details
- Filing Date
- Feb 24, 2026
- Transaction Date
- Feb 20, 2026
- Accession Number
- 0001159036-26-000028
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 20, 2026 | Common Stock | 16,757 | — | Exercise | — |
| Feb 20, 2026 | Common Stock | 9,040 | $70.98 | Tax Withholding | $641.7K |
| Feb 23, 2026 | Common Stock | 22,436 | — | Exercise | — |
| Feb 23, 2026 | Common Stock | 12,104 | $70.64 | Tax Withholding | $855.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 20, 2026 | Derivative | 16,757 | — | Exercise | — |
| Feb 23, 2026 | Derivative | 22,436 | — | Exercise | — |
Footnotes
- (F1)The reported disposition of 9,040 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- (F2)The reported disposition of 12,104 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- (F3)This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.